Nutritional supplement for diabetics

• US 5,614,224 A
• Filed: 04/20/1995
• Issued: 03/25/1997
• Est. Priority Date: 04/20/1995
• Status: Expired due to Fees

• Current Assignee: Rick W. Womack
• Original Assignee: Rick W. Womack
• Inventors: Womack, Rick W.
• Primary Examiner(s): Spivack, Phyllis G.
• Application Number:
  US08/425,582
• Time in Patent Office: 705 Days
• Field of Search: 424/646, 424/655, 514/561, 426/74, 426/656
• US Class Current: 424/646
• CPC Class Codes: A23L 33/16 Inorganic salts, minerals or trace elements
• CPC Class Codes: A23L 33/175 Amino acids
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/205 Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
• CPC Class Codes: A61K 33/24 Heavy metals; Compounds thereof

Abstract

A daily nutritional supplement and method of administering it to assist in the metabolism of glucose are disclosed. The supplement includes sources of vanadate and chromium as well as L-carnitine.

Claims

1. A daily nutritional supplement for improving glucose metabolism in diabetics comprising:

an effective amount of a source of chromium;

an effective amount of a source of vanadate; and

an effective amount of L-carnitine.

2. The daily nutritional supplement of claim 1 wherein the source of vanadate is vanadyl sulfate.

3. The daily nutritional supplement of claim 2 wherein the amount of vanadyl sulfate is between about 20 mg and about 150 mg.

4. The daily nutritional supplement of claim 3 wherein the source of chromium is selected from the group consisting of chromium picolinate, chromium glucose tolerance factor, and mixtures thereof.

5. The daily nutritional supplement of claim 4 wherein the source of chromium comprises between about 150 mcg and about 600 mcg chromium picolinate and between about 50 mcg and about 400 mcg chromium glucose tolerance factor.

6. The daily nutritional supplement of claim 5 wherein the amount of L-carnitine is between about 100 mg and about 1,000 mg.

7. The daily nutritional supplement of claim 6 wherein the vanadyl sulfate, chromium picolinate and L-carnitine are divided into substantially equal thirds to be taken with meals.

8. The daily nutritional supplement of claim 7 wherein the amount of vanadyl sulfate is about 60 mg.

9. The daily nutritional supplement of claim 8 wherein the amount of chromium picolinate is about 300 meg, the amount of chromium glucose tolerance factor is about 100 mcg, and the amount of L-carnitine is about 150 mg.

10. A method for enhancing the natural control of blood glucose levels in a person comprising the step of:

administering a nutritional supplement comprising effective amounts of a source of chromium, a source of vanadate, and L-carnitine.

11. The method of claim 10 wherein the source of vanadate is vanadyl sulfate.

12. The method of claim 11 wherein the source of chromium is selected from the group consisting of chromium picolinate, chromium glucose tolerance factor, and mixtures thereof.

13. The method of claim 12 wherein the source of chromium is chromium picolinate.

14. The method of claim 13 wherein the daily dose of chromium picolinate ranges between about 150 mcg and about 600 mcg per day;

wherein the daily dose of vanadyl sulfate ranges between about 20 mg and about 150 mg per day; and

wherein the daily dose of L-carnitine ranges between about 100 mg and about 1,000 mg per day.

15. The method of claim 14 wherein the administered dose of vanadyl sulfate is about 60 mg per day.

16. The method of claim 15 wherein the source of chromium further comprises a daily dose of between about 50 mcg and about 400 mcg chromium glucose tolerance factor.

17. The method of claim 16 wherein the daily doses are administered in substantially equal portions with three meals throughout the day.

18. The method of claim 10 wherein the person has diabetes, and wherein the supplement is administered to reduce the amount of insulin required to control blood glucose levels.

19. The method of claim 17 further comprising the step of:

continuing to administer the supplement for a period of between about five weeks and about one year.